Literature DB >> 8752582

Potentiated cAMP rise in metabotropically stimulated rat cultured astrocytes by a Ca2+-related A1/A2 adenosine receptor cooperation.

T Ogata1, Y Nakamura, P Schubert.   

Abstract

Adenosine agonists favoured an intracellular Ca2+ rise in cultured type 1 astrocytes if the metabotropic glutamate receptors were concomitantly stimulated by (2S, 1's, 2's)-2-(carboxycyclopropyl)glycine (L-CCG-I; group II agonist), quisqualate (group I agonist) or 1-aminocyclopentane-trans-1, 3-dicarboxylic acid (t-ACPD; groupI/II agonist). Since the generation of a Ca2+ signal reflected a newly adopted adenosine A1 receptor action, we tested the possible consequence that the established opposing control of the cellular cAMP content by inhibitory A1 and stimulatory A2 receptor activation was also altered. During metabotropic receptor stimulation by LCCG-I, quisqualate or t-ACPD, the non-selective adenosine agonist 2-chloroadenosine (Cl-adenosine) caused a potentiated cAMP increase which markedly exceeded that produced by Cl-adenosine alone. This cAMP potentiation resulted from altered and Ca2+-dependent A1/A2 receptor cooperation. It was abolished by A1 receptor blockade and could not be achieved in the presence of t-ACPD by the A1 agonist R(-)N6-(2-phenylisopropyl)-adenosine or by the A2 agonist 5'-N-ethyl carboxyamidoadenosine alone, but obtained using their combination. The cAMP potentiation was blocked by intracellular Ca2+ chelation and the required A1 receptor action could be mimicked by a Ca2+ signal generated by the P2y receptor agonist adenosine 5'-(beta-thio)diphosphate. The results support the conclusion that nanomolar concentrations of adenosine may influence astrocyte reactions by stimulating Ca2+ and cAMP-dependent signalling cascade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752582     DOI: 10.1111/j.1460-9568.1996.tb01280.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas.

Authors:  D F Condorelli; P Dell'Albani; M Corsaro; R Giuffrida; A Caruso; A Trovato Salinaro; F Spinella; F Nicoletti; V Albanese; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

Review 2.  Purinoceptors on neuroglia.

Authors:  Alexei Verkhratsky; Alexei Verkhrasky; Oleg A Krishtal; Geoffrey Burnstock
Journal:  Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.590

Review 3.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro.

Authors:  A J Chesi; T W Stone
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

5.  Tuning and fine-tuning of synapses with adenosine.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

6.  Differential modulation of ATP-induced calcium signalling by A1 and A2 adenosine receptors in cultured cortical astrocytes.

Authors:  Susanna Alloisio; Carlo Cugnoli; Stefano Ferroni; Mario Nobile
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

7.  Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells.

Authors:  C Brodie; P M Blumberg; K A Jacobson
Journal:  FEBS Lett       Date:  1998-06-12       Impact factor: 4.124

8.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.